MedPath

PowerLIFE Mecozin CR + ALA Plus Film Coated Tablet

Registration Number: MAL24116059NC

Approved
Approval ID

ddc2df0e788b0bce

Registration Number

MAL24116059NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types5 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (5)

30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved
90 TabletsAvailable
Package Size: 90 Tablets
Status: NPRA Approved
120 TabletsAvailable
Package Size: 120 Tablets
Status: NPRA Approved
180 TabletsAvailable
Package Size: 180 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (8)

INOSITOLActive
Monograph: 肌醇
FOLIC ACIDActive
Monograph: 叶酸
BENFOTIAMINEActive
Monograph: 苯磷硫胺
CHROMIUM POLYNICOTINATEActive
Monograph: chromium polynicotinate
ALPHA LIPOIC ACIDActive
Monograph: 硫辛酸
METHYLCOBALAMINActive
Monograph: 甲钴胺
D-CALCIUM PANTOTHENATEActive
Monograph: d-calcium pantothenate
PYRIDOXINE HYDROCHLORIDEActive
Monograph: 维生素B6

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PowerLIFE Mecozin CR + ALA Plus Film Coated Tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform